Betahistin Dimesylate
Betahistin Dimesylate’s active substance binds to two histamine receptors and is used to treat Meniere’s disease and hydrops cochlea.
Formula: C10H20N2O6S2
Molecular weight: 328.41 g/mol
Molecular size: Small
Controlled Substance: No
Precursor: No
Indications: Other nervous system drugs
Axano Pharmaceuticals Ltd
- malta europe
- admin @axanopharmamalta.com
- [email protected]
- contact details
- Malta +356 27780827